Role of Biotechnology in Drug Delivery for Cancer
Publisher
Springer New York
Reference52 articles.
1. Arena S, Pisacane A, Mazzone M, et al. Genetic targeting of the kinase activity of the Met receptor in cancer cells. PNAS 2007;104:11412-7.
2. Al-Batran SE, Bischoff J, von Minckwitz G, et al. The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial. Br J Cancer 2006;94:1615-20.
3. Badgwell BD, Valentino DJ, Jeffes EB, et al. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunol Immunother 2003;52:10-6.
4. Baish JW, Stylianopoulos T, Lanning RM, et al. Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Natl Acad Sci U S A 2011;108:1799-803.
5. Biju SS, Talegaonkar S, Mishra PR, Khar RK. Vesicular systems: An overview. Indian J Pharm Sci 2006;68:141-53.